Vamshi Krishna Lekkala, N Siva Subramanian, K Srikanth Gupta
Vamshi Krishna Lekkala1*, N Siva Subramanian2, K Srikanth Gupta3
1Group Leader, Formulation Development, Asphar Labs, Hyderabad, Telangana, India.
2Associate Professor, Periyar College of Pharmaceutical Sciences, Trichy-21, Tamilnadu.
3Scientist, Formulation Research and Development, Aizant Drug Research Solutions, Hyderabad, Telangana, India.
Volume - 13,
Issue - 6,
Year - 2020
Losartan potassium (LP) is an orally active non-peptide angiotensin -II receptor antagonist, used in the treatment of hypertension and have narrow therapeutic index, short biological half-life (1-2h), poor bio availability (25-35%), Due to these reasons conventional tablets should administer 3-4 times per day to maintain plasma drug concentrations within the therapeutic window. To overcome these drawbacks, sustained release gastro retentive floating tablets were prepared to enhance the patient compliance. Floating tablets were prepared with different grades of Hypromellose polymers along with Sodium bicarbonate, citric acid and characterized (Pre and post compression parameters) to optimize the best formulation. Lubricated blend was characterized for angle of repose, bulk density, tapped density and compressibility index. Compressed tablets were characterized for Hardness, friability, assay, related substances, in vitro drug release, etc. Based on the results, it was concluded that LFT10 formulation prepared with combination of Metolose 90SH-4000SR and Metolose 90SH-100000SR was optimized as best formulation. In vitro dissolution data of best formulation fitted in different mathematical models like zero, first orders, Higuchi, Hixon Crowell and Korsmeyer Peppas models and found that the drug release following zero order, non fickian diffusion mechanism. The optimized formulation (LFT10) also exposed to accelerated stability condition (40°C/ 75%RH) and found satisfactory as per ICH guidelines.
Cite this article:
Vamshi Krishna Lekkala, N Siva Subramanian, K Srikanth Gupta. Effect of Formulation Variables of Gastroretentive Floating Tablets of an Anti-Hypertensive agent using different Grades of Hydrophillic Polymers. Research J. Pharm. and Tech 2020; 13(6): 2893-2900. doi: 10.5958/0974-360X.2020.00516.8
Vamshi Krishna Lekkala, N Siva Subramanian, K Srikanth Gupta. Effect of Formulation Variables of Gastroretentive Floating Tablets of an Anti-Hypertensive agent using different Grades of Hydrophillic Polymers. Research J. Pharm. and Tech 2020; 13(6): 2893-2900. doi: 10.5958/0974-360X.2020.00516.8 Available on: https://rjptonline.org/AbstractView.aspx?PID=2020-13-6-66
1. Rout Prasant Kumar, Ghosh Amitava, Nayak Udaya Kumar and Nayak Bhabani Shankar. Formulation Design, Preparation of Losartan Potassium Microspheres by W/O Emulsion Solvent Evaporation Method and It’s In Vitro Characterization. Research J. Pharm. and Tech. July-Sept. 2009 2 (3)
2. Goa KL, Wagstaff AJ. Losartan potassium: a review of its pharmacology, clinical efficacy and tolerability in the management of hypertension. Drugs 1996 51 (5):820-45
3. Sica DA, Gehr TW, Ghosh S. Clinical pharmacokinetics of losartan. Clin Pharmacokinet 2005 44(8):797-814.
4. Lo MW, Goldberg MR, McCrea JB, Lu H, Furtek CI, Bjornsson TD.. Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans. Clin Pharmacol Ther. 1995 858 (6):641-649.
5. Vohra DD, Pagi KS, Rajesh KS. Losartan potassium loaded sustained release matrix tablets: Influence of various hydrophilic and hydrophobic polymers on drug release behavior. J Pharm Bioallied Sci. 2012. 4(1): S79-S80.
6. Umekar M.J., Biyani D.M., Amgaonkar Y.M., Bhoyar P.K., Lade U.B. and Kalsait R.P., Formulation Development and Evaluation of Transdermal Drug Delivery System of Antihypertensive Drug. Research J. Pharm. and Tech. July-Sept. 2010 3(3):
7. Shams MS, Alam MI, Ali A, Sultana Y, Aqil M, Shakeel F. Pharmacokinetics of a losartan potassium released from a transdermal therapeutic system forthe treatment of hypertension. Pharmazie 2010 65: 679–682.
8. N Arunkumar, C Rani and KP Mohanraj. Formulation and In Vitro evaluation of oral floating tablets of atorvastatin calcium. Research J. Pharm. and Tech. Oct.-Dec. 2008 1(4)
9. YB Ubarhande, T Regupathy, C Vijaya and SV Deshmane. Formulation and Evaluation of Mucoadhesive Buccal Films of Losartan Potassium. Research J. Pharm. and Tech. Oct.-Dec. 2009.2 (4)
10. Varma MM, Suneetha S and Raju DB. Design and Evaluation of Floating Drug Delivery System of Furosemide., Research J. Pharm. and Tech. April- June 2010 3(2).
11. Tom Damien, Someshwara Rao B., Ashok Kumar P., Amith S. Yadav and Suresh V. Kuikarni., Formulation and Evaluation Theophylline Floating Tablets and the Effect of Citric Acid on Release., Oct.-Dec. 2010 Research J. Pharm. and Tech. 3(4).
12. K. Gnanaprakash1, K.B. Chandhra Shekhar and C. Madhu Sudhana Chetty., A Review on Floating Drug Delivery System of H2 Receptors., Research J. Pharm. and Tech. April 2011 4(4).
13. Chandra Mohan Sahu, D.K. Tiwari, S.J. Ingale and A.K. Singhai., Formulation and Physicochemical Evaluation of Floating Tablets of Captopril., Research J. Pharm. and Tech August 2011. 4(8).
14. Kanij Fatema1, Md. Zakiur Rahman2, Tasnuva Haque1, Muhammad Shahidul Islam1 and Sayma Ara Dayna. Assessment and In Vitro Release Profiles of Salbutamol Sulphate from Hypromellose and Carbomer Based Matrix Tablets. Research J. Pharm. and Tech. April- June 2010 3(2):
15. Sahu Chandra Mohan, et al., Design and In-vitro Buoyancy Evaluation of Floating Tablets of Diltiazem Hydrochloride., Research J. Pharm. and Tech. March 2012 5 (3):
16. Kabita Banik, Dr. Y Phalguna, B Sangeetha., Formulation and Evaluation of Propranolol HCl Floating Tablets- A Gastro Retentive Drug Delivery., Res. J. Pharma. Dosage Forms and Tech.2019; 11(3):169-172.
17. Itishree Jogamaya Das, Himansu Bhusan Samal, Sthithapragnya Panda, Saiveena Parvathapuram, Sai Kiran Rallapalli. Formulation Design and Characterization of Lamivudine Controlled Release Matrix Tablets. Asian Journal of Pharmaceutics 2017 11 (2): S320-S326.
18. Jamakandi VG, Shivanand SG. Formulation, Characterisation and Evaluation of Controlled Release Matrix Tablets of A Model Antiviral Drug. Int. J. Pharm. Sci. Rev. Res 2018.51(2): 1-6.
19. Gharti KP, Thapa P, Budhathoki U, Bhargava A. Formulation and in vitro evaluation of floating tablets of hydroxypropyl methylcellulose and polyethylene oxide using ranitidine hydrochloride as a model drug. J Young Pharm 2012 4(4): 201–208.
20. Harekrishna Roy, Chandan K Brahma, Sisir Nandi, Kirti R Parida. Formulation and design of sustained release matrix tablets of metformin hydrochloride: Influence of hypromellose and polyacrylate polymers. Int J Appl Basic Med Res 2013 3(1): 55–63.
21. Rupali Kirtawade et al., Simultaneous UV-spectrophotometric Method for Estimation of Atenolol and Losartan Potassium in Tablet Dosage Form. Asian J. Research Chem Oct. - Dec. 2010 3(4).
22. Kifayat Ullah Shah, Gul Majid Khan. Regulating Drug Release Behavior and Kinetics from Matrix Tablets Based on Fine Particle-Sized Ethyl Cellulose Ether Derivatives: An In Vitro and In Vivo Evaluation. Scientific World Journal. 2012 842348.
23. Gouda R, Baishya H, Qing Z. Application of Mathematical Models in Drug Release Kinetics of Carbidopa and Levodopa ER Tablets. J Develop Drugs 2017 6(2): 171.
24. Mayur Karvekar, Arshad Bashir Khan. A Brief Review on Sustained Release Matrix Type Drug Delivery System. Journal of Pharmaceutical Research. 2017 16 (3): 282-289.
25. Juergen Siepmann, Nicholas A. Peppas. Higuchi equation: Derivation, applications, use and misuse. International Journal of Pharmaceutics. 2011. 418 (1): 6-12
26. Suvakanta Dash, Padala Narasimha Murthy, Lilakanta Nath, Prasanta Chowdhury. Kinetic modeling on drug release from controlled drug delivery systems. Acta Poloniae Pharmaceutica-Drug Research. 2010 67 (3): 217-223.
27. Stability testing of new drug substances and products Q1A (R2). Dt.6 Feb 2003